Below is today’s SmartApingAI snapshot of three highly oversold names showing early signs of a rebound. Scroll down for a quick refresher on each company’s fundamentals, key technicals, and what makes them attractive at current levels.
1. Masco Corp (
MAS )
What They Do:
Masco designs, manufactures and sells a broad range of home-improvement and new-construction products, including faucets, cabinets, hardware, coatings and architectural products.
Customers:
• Homeowners tackling renovation projects
• Professional contractors and builders
Income Source:
Primarily through the sale of mid-range to premium fixtures, cabinetry systems and paint/coatings.
Geographic Footprint:
• ~85% North America
• ~15% Europe
Product Pricing:
Mid-range to premium, with strong brand recognition in kitchen and bath fixtures.
SmartAping AI Model Target Price:
$81.36
Technical Snapshot:
• Broke below—and then bounced off—the $57 weekly support zone
• Now trading at $60.42, up from the intra-week low
• WiseStrat Macro ASI: deeply oversold at –120, turning bullish
• WiseStrat Micro ASI: still bearish, suggesting cautious position sizing
Why Watch:
Home-improvement spending has held up despite moderating housing starts, and MAS’s disciplined balance sheet and dividend yield (~2%) make it a compelling recovery play if consumer confidence picks up.
2. IQVIA Holdings Inc (
IQV )
What They Do:
IQVIA provides data analytics, research services and technology solutions that power clinical trials, market research and real-world evidence for the life-sciences industry.
Customers:
• Pharma and biotech firms
• Medical device companies
• Healthcare providers and payers
Income Source:
Subscription and project-based fees for data platforms, consulting and trial execution services.
Geographic Footprint:
• 50% Americas
• 30% EMEA (Europe, Middle East & Africa)
• 20% Asia-Pacific
Product Pricing:
Variable, tailored to project scope—from high-volume data subscriptions to multi-million-dollar trial outsourcing contracts.
SmartAping AI Model Target Price:
$275.35
Technical Snapshot:
• Dropped below the $137 weekly support last week, then staged a relief rally
• Currently at $150.28
• WiseStrat Macro ASI: extremely oversold at –127, now in bullish reversal mode
• WiseStrat Micro ASI: turning positive, hinting at building short-term momentum
Why Watch:
With global R&D spend on track to exceed $250 billion this year, IQVIA’s blend of analytics and CRO services is in high demand. A seasonal uptick in trial starts could catalyze upside toward our $275 target.
3. Thermo Fisher Scientific Inc (
TMO )
What They Do:
Thermo Fisher supplies scientific instruments, reagents and software used in research, diagnostics, manufacturing and safety testing across life-sciences and industrial markets.
Customers:
• Academic, government and corporate research labs
• Clinical and diagnostic facilities
• Biopharma manufacturers
Income Source:
Sales of equipment (from a few hundred to multi-million dollars), consumables, and service contracts.
Geographic Footprint:
• ~50% North America
• ~30% Europe
• ~20% Asia-Pacific & other
Product Pricing:
Ranges widely: entry-level lab kits to high-end sequencers and complete lab automation lines.
SmartAping AI Model Target Price:
$645.83
Technical Snapshot:
• Tested and held the $412.73 weekly support last week, bouncing back to $424.24
• WiseStrat Macro ASI: oversold at –129, now showing bullish tilt
• WiseStrat Micro ASI: still negative, cautioning potential retest of $412
Why Watch:
Strong long-term secular drivers—gene therapy, personalized medicine and diagnostics—remain intact. A washout in biotech funding fears has left TMO trading at a rare discount to growth peers.
1. Masco Corp (
MAS )What They Do:
Masco designs, manufactures and sells a broad range of home-improvement and new-construction products, including faucets, cabinets, hardware, coatings and architectural products.
Customers:
• Homeowners tackling renovation projects
• Professional contractors and builders
Income Source:
Primarily through the sale of mid-range to premium fixtures, cabinetry systems and paint/coatings.
Geographic Footprint:
• ~85% North America
• ~15% Europe
Product Pricing:
Mid-range to premium, with strong brand recognition in kitchen and bath fixtures.
SmartAping AI Model Target Price:
$81.36
Technical Snapshot:
• Broke below—and then bounced off—the $57 weekly support zone
• Now trading at $60.42, up from the intra-week low
• WiseStrat Macro ASI: deeply oversold at –120, turning bullish
• WiseStrat Micro ASI: still bearish, suggesting cautious position sizing
Why Watch:
Home-improvement spending has held up despite moderating housing starts, and MAS’s disciplined balance sheet and dividend yield (~2%) make it a compelling recovery play if consumer confidence picks up.
2. IQVIA Holdings Inc (
IQV )What They Do:
IQVIA provides data analytics, research services and technology solutions that power clinical trials, market research and real-world evidence for the life-sciences industry.
Customers:
• Pharma and biotech firms
• Medical device companies
• Healthcare providers and payers
Income Source:
Subscription and project-based fees for data platforms, consulting and trial execution services.
Geographic Footprint:
• 50% Americas
• 30% EMEA (Europe, Middle East & Africa)
• 20% Asia-Pacific
Product Pricing:
Variable, tailored to project scope—from high-volume data subscriptions to multi-million-dollar trial outsourcing contracts.
SmartAping AI Model Target Price:
$275.35
Technical Snapshot:
• Dropped below the $137 weekly support last week, then staged a relief rally
• Currently at $150.28
• WiseStrat Macro ASI: extremely oversold at –127, now in bullish reversal mode
• WiseStrat Micro ASI: turning positive, hinting at building short-term momentum
Why Watch:
With global R&D spend on track to exceed $250 billion this year, IQVIA’s blend of analytics and CRO services is in high demand. A seasonal uptick in trial starts could catalyze upside toward our $275 target.
3. Thermo Fisher Scientific Inc (
TMO )What They Do:
Thermo Fisher supplies scientific instruments, reagents and software used in research, diagnostics, manufacturing and safety testing across life-sciences and industrial markets.
Customers:
• Academic, government and corporate research labs
• Clinical and diagnostic facilities
• Biopharma manufacturers
Income Source:
Sales of equipment (from a few hundred to multi-million dollars), consumables, and service contracts.
Geographic Footprint:
• ~50% North America
• ~30% Europe
• ~20% Asia-Pacific & other
Product Pricing:
Ranges widely: entry-level lab kits to high-end sequencers and complete lab automation lines.
SmartAping AI Model Target Price:
$645.83
Technical Snapshot:
• Tested and held the $412.73 weekly support last week, bouncing back to $424.24
• WiseStrat Macro ASI: oversold at –129, now showing bullish tilt
• WiseStrat Micro ASI: still negative, cautioning potential retest of $412
Why Watch:
Strong long-term secular drivers—gene therapy, personalized medicine and diagnostics—remain intact. A washout in biotech funding fears has left TMO trading at a rare discount to growth peers.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.